Sunday, October 2, 2016

DEPO Wins Patent Suit, EBS Surges On BARDA Funding, REGN's Eylea Combo Fails

Shares of Depomed Inc. (DEPO) touched a new 52-week high on Friday, thanks to the patent infringement suit related to NUCYNTA franchise going in favor of the company.

from RTT - Biotech http://ift.tt/2dApqPV
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)